Anxiety Insights

Calendar

««	Jul 2007					»»
S	M	T	W	T	F	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

LinkBlog

'Managing Holiday Stress' a LifeCare® guide (PDF)

Generalized Anxiety Disorder - Patient treatment manual (pdf)

Understanding post-traumatic stress disorder

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

July 2007

Flawed science behind claims grief counseling harmful

Tuesday, 31 July 2007 8:33 A GMT+01

Despite frequent claims to the contrary, there is no empirical or statistical evidence to suggest that grief counseling is harmful to clients, or that clients who are "normally" bereaved are at special risk if they receive grief counseling,

Genes influence emotional memory

Tuesday, 31 July 2007 7:52 A GMT+01

A single gene can influence how clearly you recall emotionally intense memories, neuroscientists have shown.

Stressed mothers-to-be deliver problem sleepers

Monday, 30 July 2007 9:57 A GMT+01

Anxious or depressed mothers-to-be are at increased risk of having children who will experience sleep problems in infancy and toddlerhood, according to a study published in the journal Early Human Development.

Binary regression model predicts antidepressant response to rTMS

Monday, 30 July 2007 9:05 A GMT+01

MedWire News: Depressed patients with more sleep disturbances, low treatment-resistance, and short duration of episode are more likely to respond to repetitive transcranial magnetic stimulation (rTMS) than other patients, German researchers have disc

Audio cast: What ketamine reveals about depression

Saturday, 28 July 2007 10:08 A GMT+01

Depression medication usually takes weeks to kick in. But one drug, ketamine, starts working in hours. In new research published this week in the journal Biological Psychiatry, scientists say they have a better idea of how the drug, also used as an a

Are antidepressants taking the edge off love?

Saturday, 28 July 2007 8:24 A GMT+01

Sure, we know about the sexual side effects of SSRIs. But researchers now wonder if that's the only aspect of romance the drugs can influence.

Multidimensional approach recommended for fibromyalgia treatment

Saturday, 28 July 2007 8:20 A GMT+01

Management of fibromyalgia requires a multidimensional approach including patient education, cognitive behavioral therapy, exercise, and other treatment, according to a review published in the July 15 issue of American Family Physician.

Brains of severely traumatized children function differently

Friday, 27 July 2007 10:02 A GMT+01

The first study to examine brain activity patterns in severely traumatized children showed their brains function differently than those of healthy children, say researchers

Physical health problems often accompany PTSD

Friday, 27 July 2007 9:58 A GMT+01

NEW YORK (Reuters Health) - People who develop post-traumatic stress disorder (PTSD) after experiencing a disaster may also face an increased risk of physical health problems, Dutch researchers report.

Social interactions affect mood more the older we get

Friday, 27 July 2007 9:56 A GMT+01

Elderly Chinese aged 70+ have stronger emotional responses to the interactions with others than those aged 60-69, a University of Michigan study found.

Psychotherapy effective in short term for depressed children, adolescents

Friday, 27 July 2007 9:41 A GMT+01

MedWire News: Psychotherapies, especially cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT), are more effective than no treatment in children and adolescents with depression, but the effects are only short term, meta-analysis results

Abstract: Amygdala and hippocampal volumes in familial early onset major depressive disorder

Friday, 27 July 2007 9:39 A GMT+01

Abnormalities in the amygdala and hippocampus have been implicated in the pathogenesis of major depressive disorder (MDD). To our knowledge, no prior study has examined amygdala-hippocampus anatomy in pediatric patients with familial MDD

Postnatal depression need not preclude breastfeeding

Thursday, 26 July 2007 10:29 A GMT+01

The commonly held belief that mothers with postnatal depression will not be able to breastfeed has been challenged by research from the University of Leicester,

Maternal depression predicts ADHD in kids

Thursday, 26 July 2007 10:27 A GMT+01

A diagnosis of maternal depression any time between 1 year before and 9 years after giving birth is a risk factor for attention-deficit/hyperactivity disorder in school-age children,

Antidepressants may lift metabolic syndrome risk

Thursday, 26 July 2007 10:26 A GMT+01

Antidepressant use could be associated with an increased risk of metabolic syndrome among adult psychiatric inpatients, Stephen B. Woolley, D.Sc., reported at the annual meeting of the American Psychiatric Association.

Abstract+: Issues in the pharmacological treatment of Obsessive-Compulsive Disorder

Thursday, 26 July 2007 10:24 A GMT+01

Obsessive-compulsive disorder (OCD) preferentially responds to a class of antidepressants called serotonin reuptake inhibitors.[SRI] This review discusses certain issues unique to pharmacological treatment of OCD

Australian teens a stressed out lot

Thursday, 26 July 2007 10:20 A GMT+01

Body image, family breakdown, early physical maturity and the shadow of war are combining to produce "the most vulnerable generation" of Australians ever, experts in adolesent anxiety believe.

Albert Ellis, influential figure in modern psychology, dies at 93

Wednesday, 25 July 2007 9:30 A GMT+01

Albert Ellis, whose innovative straight-talk approach to psychotherapy made him one of the most influential and provocative figures in modern psychology, died early today [July 24] at his home

Work stress precipitates depression and anxiety in young workers

Wednesday, 25 July 2007 9:27 A GMT+01

Work stress appears to trigger the occurrence of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in previously healthy young workers, study results indicate.

For anxiety, look beyond status quo drugs: Augmentation most commonly involves atypicals; benzodiazepines or buspirone; and anticonvulsants.

Wednesday, 25 July 2007 9:25 A GMT+01

Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are first-line pharmacotherapy for most patients with generalized anxiety disorder and social anxiety disorder, but a substantial number of patients need more.

Abstract: Interaction between smoking rate and anxiety sensitivity

Wednesday, 25 July 2007 9:21 A GMT+01

The aim of the present investigation was to evaluate the moderating role of anxiety sensitivity (AS) in the relation between smoking rate and panic vulnerability variables, both concurrently and prospectively (3 months),

Psilocybin results inspire researchers

Wednesday, 25 July 2007 9:19 A GMT+01

A cadre of academics has begun conducting new research into the use of psychedelic drugs for mental illness; initial results are intriguing enough to warrant further exploration, several of the researchers said

Anesthetic points way to faster-acting antidepressants

Wednesday, 25 July 2007 1:37 A GMT+01

Experimental medication ketamine relieves depression in just hours - points to targets for new medications

Hopelessness key factor in 'double depression'

Tuesday, 24 July 2007 9:23 A GMT+01

There's depression, and then there's double depression. Sound bad? It is, according to Thomas Joiner, Florida State University Distinguished Research Professor and the Bright-Burton Professor of Psychology,

FDA rejects salt formulation of bupropion antidepressant

Tuesday, 24 July 2007 9:14 A GMT+01

Biovail Corporation has confirmed that it received a Non-Approval letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for BVF-033, a novel once-daily salt formulation of bupropion (Wellbutrin®).

Calendar

archives

Search Box

Ai in the media